Inventor · disambiguated record
Runsheng Li
Also filed as: LI RUNSHENG
15 granted patents·16 pending applications·11 citations·filing 2019–2025
87Inventor score
Files withLANOVA MEDICINES LTD13LANOVA MEDICINES DEV CO LTD7LANOVA MEDICINES LTD COMPANY6UNIV HUAZHONG SCIENCE TECH3LA NOVA MEDICINES DEV CO LTD1
Top patents by PatentIndex Score
31 records- 0193US11873342B2Anti-CCR8 monoclonal antibodies and uses thereofLANOVA MEDICINES LTD·Filed 2022·Granted Jan 16, 2024·3 cites·9 claims
- 0293US11098118B2Anti-claudin 18.2 antibodies and uses thereofLANOVA MEDICINES LTD COMPANY·Filed 2021·Granted Aug 24, 2021·3 cites·6 claims
- 0388US11059887B2Anti-claudin 18.2 antibodies and uses thereofLANOVA MEDICINES LTD COMPANY·Filed 2019·Granted Jul 13, 2021·3 cites·3 claims
- 0487US11554177B2Antibody-drug conjugates targeting human Claudin 18.2LANOVA MEDICINES LTD COMPANY·Filed 2021·Granted Jan 17, 2023·1 cites·22 claims
- 0586US11485783B2Anti-GPRC5D monoclonal antibodies and uses thereofLANOVA MEDICINES DEV CO LTD·Filed 2022·Granted Nov 1, 2022·1 cites·24 claims
- 0684US2025011419A1Anti-claudin 18.2 antibodies and uses thereofLANOVA MEDICINES LTD·Filed 2024·Application pending·0 cites
- 0776US12194106B2Antibodies targeting LIV-1 and uses thereofLANOVA MEDICINES LTD·Filed 2024·Granted Jan 14, 2025·0 cites·20 claims
- 0875US12324936B2Methods of treating cancer by administering an antibody-drug conjugate targeting human claudin 18.2LANOVA MEDICINES LTD COMPANY·Filed 2022·Granted Jun 10, 2025·0 cites·19 claims
- 0975US12281162B2Chimeric antigen receptors targeting GPRC5DLANOVA MEDICINES DEV CO LTD·Filed 2022·Granted Apr 22, 2025·0 cites·20 claims
- 1075US12180276B2Antibodies and antibody-drug conjugates targeting claudin 6LANOVA MEDICINES LTD·Filed 2024·Granted Dec 31, 2024·0 cites·26 claims
- 1175US12018076B2Anti-claudin 18.2 antibodies and uses thereofLANOVA MEDICINES LTD COMPANY·Filed 2021·Granted Jun 25, 2024·0 cites·9 claims
- 1274US12247081B2CEACAM5-dependent 4-1BB-agonistic bispecific antibodiesLANOVA MEDICINES LTD·Filed 2024·Granted Mar 11, 2025·0 cites·18 claims
- 1374US12215150B2Anti-SLC34A2 monoclonal antibodies and uses thereofLANOVA MEDICINES DEV CO LTD·Filed 2024·Granted Feb 4, 2025·0 cites·17 claims
- 1473US2025339550A1Antibody-drug conjugates targeting human claudin 18.2LANOVA MEDICINES LTD COMPANY·Filed 2025·Application pending·0 cites
- 1572US12291537B2Compounds, compositions and methodsLANOVA MEDICINES LTD·Filed 2024·Granted May 6, 2025·0 cites·19 claims
- 1672US2025109200A1Antibodies and antibody-drug conjugates targeting claudin 6LANOVA MEDICINES LTD·Filed 2024·Application pending·0 cites
- 1772US2024141052A1Anti-ccr8 monoclonal antibodies and uses thereofLANOVA MEDICINES LTD·Filed 2023·Application pending·0 cites
- 1870US2025388671A1Chimeric antigen receptors targeting gprc5dLANOVA MEDICINES DEV CO LTD·Filed 2025·Application pending·0 cites
- 1967US2024383993A1Anti-4-1bb nanobodiesLANOVA MEDICINES LTD·Filed 2022·Application pending·0 cites
- 2065US2025320307A1Anti-4-1bb nanobodiesLANOVA MEDICINES LTD·Filed 2025·Application pending·0 cites
- 2163US12434298B2Wire arc additive manufacturing-spinning combined machining device and methodUNIV HUAZHONG SCIENCE TECH·Filed 2022·Granted Oct 7, 2025·0 cites·20 claims
- 2262US2025270228A1Compounds, compositions and methodsLANOVA MEDICINES LTD·Filed 2025·Application pending·0 cites
- 2360US2025163164A1Anti-il-13ra2 monoclonal antibodies and uses thereofLANOVA MEDICINES DEV CO LTD·Filed 2023·Application pending·0 cites
- 2459US2025206834A1Ceacam5-dependent 4-1bb-agonistic bispecific antibodiesLANOVA MEDICINES LTD·Filed 2025·Application pending·0 cites
- 2559US2024400701A1Anti-amhrii antibodiesLANOVA MEDICINES DEV CO LTD·Filed 2022·Application pending·0 cites
- 2656US2025154248A1Anti-slc34a2 monoclonal antibodies and uses thereofLANOVA MEDICINES DEV CO LTD·Filed 2025·Application pending·0 cites
- 2755US2025186601A1Antibodies targeting liv-1 and uses thereofLANOVA MEDICINES LTD·Filed 2025·Application pending·0 cites
- 2852US12403540B2Welding bead modeling method for wire-arc additive manufacturing, device therefor and system thereforUNIV HUAZHONG SCIENCE TECH·Filed 2020·Granted Sep 2, 2025·0 cites·20 claims
- 2951US2024101716A1BISPECIFIC ANTIBODIES TARGETING SIRPa AND PD-L1LA NOVA MEDICINES DEV CO LTD·Filed 2021·Application pending·0 cites
- 3050US2021139977A1Method for identifying RNA isoforms in transcriptome using Nanopore RNA readsUNIV HONG KONG BAPTIST UNIV·Filed 2020·Application pending·0 cites
- 3146US2021187670A1System and method for detecting and regulating microstructure online with electromagnetic assistanceUNIV HUAZHONG SCIENCE TECH·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Runsheng Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →